人类氨酸白血CysLT1受体的表征

K R Lynch1, G P O'Neill, Q Liu

  • 1Department of Pharmacology, University of Virginia Health Sciences Center, Charlottesville 22908, USA.

Nature
|July 3, 1999
PubMed
概括

研究人员克隆了人类cysteinyl leukotriene受体1 (CysLT1) 用于喘治疗. 这种受体被白血D4和白血C4激活,并被CysLT1抗剂 (如蒙特卢卡斯特) 向.